We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
AUM
$3.36B
AUM Growth
+$82M
Cap. Flow
+$65.6M
Cap. Flow %
1.95%
Top 10 Hldgs %
33.03%
Holding
318
New
25
Increased
113
Reduced
72
Closed
11

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$22.7M
2
BURL icon
Burlington
BURL
+$14.9M
3
PRCT icon
Procept Biorobotics
PRCT
+$13.9M
4
DELL icon
Dell
DELL
+$10.2M
5
ASML icon
ASML
ASML
+$7.37M

Top Sells

Rank Stock Value
1
DV icon
DoubleVerify
DV
+$45.6M
2
PGR icon
Progressive
PGR
+$16.3M
3
TDC icon
Teradata
TDC
+$14.4M
4
NFLX icon
Netflix
NFLX
+$13.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$7.45M

Sector Composition

Rank Sector Weight
1 Technology 31.04%
2 Healthcare 18.24%
3 Communication Services 14.1%
4 Financials 12.02%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
76
Procter & Gamble
PG
$336B
$5.97M 0.18%
36,181
+955
+3% +$156K
CPRT icon
77
Copart
CPRT
$27B
$5.96M 0.18%
110,065
-66,322
-38% -$3.62M
VRTX icon
78
Vertex Pharmaceuticals
VRTX
$121B
$5.94M 0.18%
12,669
+282
+2% +$122K
MELI icon
79
Mercado Libre
MELI
$95.2B
$5.92M 0.18%
3,602
+15
+0.4% +$23.7K
AMGN icon
80
Amgen
AMGN
$208B
$5.73M 0.17%
18,351
-567
-3% -$167K
PAYX icon
81
Paychex
PAYX
$41.6B
$5.12M 0.15%
43,187
CAT icon
82
Caterpillar
CAT
$375B
$4.92M 0.15%
14,782
+515
+4% +$179K
KO icon
83
Coca-Cola
KO
$377B
$4.72M 0.14%
74,092
+1,040
+1% +$64.4K
ABT icon
84
Abbott
ABT
$183B
$4.64M 0.14%
44,626
+2,516
+6% +$267K
MCD icon
85
McDonald's
MCD
$192B
$4.3M 0.13%
16,858
+1,950
+13% +$517K
GWW icon
86
W.W. Grainger
GWW
$65.3B
$4.18M 0.12%
4,634
-17
-0.4% -$16K
ZD icon
87
Ziff Davis
ZD
$1.96B
$4.15M 0.12%
75,474
ACN icon
88
Accenture
ACN
$102B
$4.09M 0.12%
13,491
+820
+6% +$251K
DKS icon
89
Dick's Sporting Goods
DKS
$17.5B
$3.65M 0.11%
16,990
-494
-3% -$103K
SPY icon
90
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$3.62M 0.11%
6,643
+288
+5% +$151K
VTI icon
91
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$3.56M 0.11%
13,303
+3,589
+37% +$929K
BX icon
92
Blackstone
BX
$102B
$3.46M 0.1%
27,969
+182
+0.7% +$22.4K
GPN icon
93
Global Payments
GPN
$23B
$3.43M 0.1%
35,514
CEF icon
94
Sprott Physical Gold and Silver Trust
CEF
$7.4B
$3.39M 0.1%
153,865
TSLA icon
95
Tesla
TSLA
$1.23T
$3.38M 0.1%
17,063
+399
+2% +$69.7K
ALIT icon
96
Alight
ALIT
$447M
$3.36M 0.1%
+22,745
New +$3.79M
WM icon
97
Waste Management
WM
$90.6B
$3.34M 0.1%
15,665
-275
-2% -$57.2K
PHYS icon
98
Sprott Physical Gold
PHYS
$14.6B
$3.32M 0.1%
183,978
MRK icon
99
Merck
MRK
$322B
$3.11M 0.09%
25,147
+2,960
+13% +$381K
AGG icon
100
iShares Core US Aggregate Bond ETF
AGG
$137B
$3.11M 0.09%
+32,072
New +$3.1M

Similar funds

Chicago Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Chicago Capital held 318 positions worth $3.36B, up 2.5% from $3.28B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Chicago Capital's Q2 2024 filing shows 25 new, 113 increased, 72 reduced and 11 closed positions. Its largest new stake was Procept Biorobotics: 232,983 shares worth $14.2M. The largest sale was DoubleVerify, an estimated $45.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Chicago Capital's largest Q2 2024 buy was Procept Biorobotics: 232,983 shares worth $14.2M.
  • Chicago Capital added most to Ligand Pharmaceuticals in Q2 2024, an estimated $22.7M increase.
  • Chicago Capital's biggest Q2 2024 reduction was DoubleVerify, cutting an estimated $45.6M.
  • Chicago Capital fully exited lululemon athletica in Q2 2024, selling an estimated $4.4M.
  • Chicago Capital's ten largest holdings make up 33% of its $3.36B portfolio in Q2 2024.
  • Chicago Capital opened 25 new positions and closed 11 in Q2 2024.
  • Chicago Capital's portfolio value rose 2.5% quarter-over-quarter to $3.36B.

Based on Chicago Capital's 13F filing for Q2 2024, filed 6 Aug 2024.